
    
      A total of 188 subjects will be enrolled-subjects will be equally (1:1) randomized between
      those undergoing conventional atrial fibrillation ablation with confirmation of pulmonary
      vein isolation (PVI) versus those actively treated with the FIRM procedure without PVI.
    
  